中文名称:
4-(二甲氨基)-N-[7-(羟基氨基)-7-氧庚]苯甲酰胺
中文同义词:
4-(二甲氨基)-N-[7-(羟基氨基)-7-氧庚]苯甲酰胺(组蛋白去乙酰化酶抑制剂);组蛋白去乙酰化酶抑制剂(M 344);4-二甲基氨基-N-(6-羟基氨基甲酰己基)苯甲酰胺;4-(二甲氨基)-N-[7-(羟基氨基)-7-氧庚]苯甲酰胺
英文同义词:
M344;HISTONE DEACETYLASE INHIBITOR III;4-DIMETHYLAMINO-N-(6-HYDROXYCARBAMOYLHEXYL)-BENZAMIDE;N-HYDROXY-7-(4-DIMETHYLAMINOBENZOYL)AMINOHEPTANAMIDE;HISTONE DEACETYLASE INHIBITOR III;D237;D 237;D-237;M-344;M344;CS-661;4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide, MS 344, D237, N-Hydroxy-7-(4-dimethylaminobenzoyl)-aminoheptanamide;4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide
相关类别:
小分子抑制剂;小分子抑制剂，天然产物;细胞骨架信号;细胞生物学试剂;Amines;Aromatics;Inhibitors;Apoptosis Inducers;Intermediates Fine Chemicals;Pharmaceuticals;Inhibitor
溶解度
DMSO: soluble10mg/mL, clear
生物活性
M344 (D 237) 是一种组蛋白去乙酰化酶抑制剂，IC50 为 100 nM。
体外研究
M344 is a potential histone deacetylase (HDAC) inhibitor. BRCA1 mRNA levels are determined by RT-PCR following exposure to increasing concentrations of the HDAC inhibitor M344 alone and in combination with Cisplatin in all 6 cell lines evaluated in this study. With increasing concentrations of M344, there is a dose dependant decrease in BRCA1 mRNA and treatment with both 1 and 5 μM concentrations of M344 resulting in a significant decrease in BRCA1 expression in all cell lines examined. M344 in combination with Cisplatin leads to a decrease in BRCA1 mRNA expression as compared to Cisplatin treatment alone in all cell lines with the exception of A2780s, which is recognized as having potent cytotoxicity to Cisplatin. In the MCF7 cell line, BRCA1 is down regulated at physiological doses of M344 (0.5 μM and 1 μM) but M344 does not have the same inhibitory effect on BRCA1 at the 5.0 μM dose. Co-treatment with Cisplatin and increasing concentrations of M344 reduces BRCA1 protein levels in all breast and ovarian cell lines examined.
